Huntsman DG - Search Results

1

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.

Press JZ, De Luca A, Boyd N, Young S, Troussard A, Ridge Y, Kaurah P, Kalloger SE, Blood KA, Smith M, Spellman PT, Wang Y, Miller DM, Horsman D, Faham M, Gilks CB, Gray J, Huntsman DG. Press JZ, et al. Among authors: huntsman dg. BMC Cancer. 2008 Jan 22;8:17. doi: 10.1186/1471-2407-8-17. BMC Cancer. 2008. PMID: 18208621 Free PMC article.

2

Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.

Huntsman DG, Clement PB, Gilks CB, Scully RE. Huntsman DG, et al. Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005. Am J Surg Pathol. 1994. PMID: 7511354 Review.

3

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB. Parker RL, et al. Among authors: huntsman dg. Am J Clin Pathol. 2002 May;117(5):723-8. doi: 10.1309/PEF8-GL6F-YWMC-AG56. Am J Clin Pathol. 2002. PMID: 12090420

4

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.

Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH. Tognon C, et al. Cancer Cell. 2002 Nov;2(5):367-76. doi: 10.1016/s1535-6108(02)00180-0. Cancer Cell. 2002. PMID: 12450792 Free article.

5

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.

Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB. Hsu FD, et al. Mod Pathol. 2002 Dec;15(12):1374-80. doi: 10.1097/01.MP.0000039571.02827.CE. Mod Pathol. 2002. PMID: 12481020

6

Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.

Thiessen B, Maguire JA, McNeil K, Huntsman D, Martin MA, Horsman D. Thiessen B, et al. J Neurooncol. 2003 Sep;64(3):271-8. doi: 10.1023/a:1025689004046. J Neurooncol. 2003. PMID: 14558604 Clinical Trial.

7

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.

Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D. Makretsov N, et al. Hum Pathol. 2003 Oct;34(10):1001-8. doi: 10.1053/s0046-8177(03)00411-8. Hum Pathol. 2003. PMID: 14608533

8

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.

Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE. Nielsen TO, et al. Among authors: huntsman dg. Cancer Res. 2004 Jan 1;64(1):286-91. doi: 10.1158/0008-5472.can-03-1242. Cancer Res. 2004. PMID: 14729636

9

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.

Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Alkushi A, et al. Int J Gynecol Pathol. 2004 Apr;23(2):129-37. doi: 10.1097/00004347-200404000-00007. Int J Gynecol Pathol. 2004. PMID: 15084841

10

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.

Makretsov N, He M, Hayes M, Chia S, Horsman DE, Sorensen PH, Huntsman DG. Makretsov N, et al. Among authors: huntsman dg. Genes Chromosomes Cancer. 2004 Jun;40(2):152-7. doi: 10.1002/gcc.20028. Genes Chromosomes Cancer. 2004. PMID: 15101049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters